Mitchell F. Brin
Researcher Next ID · RN-027326
Researcher · Medicine
University of California, Irvine
Irvine, Ireland
- Works count
- 332
- Citation count
- 24,943
- H-index
- 81
- i10-index
- 198
Research interests
Publications
Selective inhibition of meningeal nociceptors by botulinum neurotoxin type A: Therapeutic implications for migraine and other pains
Cephalalgia · 2014 · https://doi.org/10.1177/0333102414527648
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity
The Journal of Urology · 2012 · https://doi.org/10.1016/j.juro.2012.01.125
Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial
European Urology · 2011 · https://doi.org/10.1016/j.eururo.2011.07.002
OnabotulinumtoxinA for Treatment of Chronic Migraine: Pooled Results From the Double‐Blind, Randomized, Placebo‐Controlled Phases of the PREEMPT Clinical Program
Headache The Journal of Head and Face Pain · 2010 · https://doi.org/10.1111/j.1526-4610.2010.01678.x
Consensus Statement of the Movement Disorder Society on Tremor
Movement Disorders · 2008 · https://doi.org/10.1002/mds.870131303
BOTULINUM TOXIN TYPE A IS A SAFE AND EFFECTIVE TREATMENT FOR NEUROGENIC URINARY INCONTINENCE: RESULTS OF A SINGLE TREATMENT, RANDOMIZED, PLACEBO CONTROLLED 6-MONTH STUDY
The Journal of Urology · 2005 · https://doi.org/10.1097/01.ju.0000162035.73977.1c
Botulinum Toxin Type A for the Prophylaxis of Chronic Daily Headache: Subgroup Analysis of Patients Not Receiving Other Prophylactic Medications: A Randomized Double‐Blind, Placebo‐Controlled Study
Headache The Journal of Head and Face Pain · 2005 · https://doi.org/10.1111/j.1526-4610.2005.05068.x
A double‐blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease
Annals of Neurology · 2003 · https://doi.org/10.1002/ana.10720
A randomized, double masked, controlled trial of botulinum toxin type A in essential hand tremor
Neurology · 2001 · https://doi.org/10.1212/wnl.56.11.1523
The DYT1 phenotype and guidelines for diagnostic testing
Neurology · 2000 · https://doi.org/10.1212/wnl.54.9.1746
Botulinum toxin type A (BOTOX) for treatment of migraine headaches: An open‐label study
Otolaryngology · 2000 · https://doi.org/10.1067/mhn.2000.110960
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–resistant cervical dystonia
Neurology · 1999 · https://doi.org/10.1212/wnl.53.7.1431
Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A–responsive cervical dystonia
Neurology · 1999 · https://doi.org/10.1212/wnl.53.7.1439
Botulinum toxin management of spasmodic dysphonia (laryngeal dystonia): A 12‐year experience in more than 900 patients
The Laryngoscope · 1998 · https://doi.org/10.1097/00005537-199810000-00003
The early-onset torsion dystonia gene (DYT1) encodes an ATP-binding protein
Nature Genetics · 1997 · https://doi.org/10.1038/ng0997-40
Botulinum toxin: Chemistry, pharmacology, toxicity, and immunology
Muscle & Nerve · 1997 · https://doi.org/10.1002/(sici)1097-4598(1997)6+<146::aid-mus10>3.0.co;2-4
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
Neurology · 1997 · https://doi.org/10.1212/wnl.49.3.701
Botulinum Toxin for the Treatment of Hyperfunctional Lines of the Face
Archives of Otolaryngology - Head and Neck Surgery · 1993 · https://doi.org/10.1001/archotol.1993.01880210108015
Idiopathic cervical dystonia: Clinical characteristics
Movement Disorders · 1991 · https://doi.org/10.1002/mds.870060206
Therapeutic Uses of Botulinum Toxin
New England Journal of Medicine · 1991 · https://doi.org/10.1056/nejm199104253241707
Double‐blind, placebo‐controlled trial of botulinum toxin injections for the treatment of spasmodic torticollis
Neurology · 1990 · https://doi.org/10.1212/wnl.40.8.1213
Idiopathic dystonia among ashkenazi jews: Evidence for autosomal dominant inheritance
Annals of Neurology · 1989 · https://doi.org/10.1002/ana.410260505
Human gene for torsion dystonia located on chromosome 9q32-q34
Neuron · 1989 · https://doi.org/10.1016/0896-6273(89)90188-8
Localized injections of botulinum toxin for the treatment of focal laryngeal dystonia (spastic dysphonia)
The Laryngoscope · 1988 · https://doi.org/10.1288/00005537-198802000-00015
Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm
Movement Disorders · 1987 · https://doi.org/10.1002/mds.870020402
Current projects
No projects listed.